-
1.
公开(公告)号:US20060240422A1
公开(公告)日:2006-10-26
申请号:US10525681
申请日:2003-08-22
申请人: Henning Walczak , Martin Sprick
发明人: Henning Walczak , Martin Sprick
IPC分类号: C12Q1/68 , G01N33/574 , C12Q1/37 , A61K48/00 , A61K39/395
CPC分类号: C12Q1/37 , C12Q1/6883 , C12Q2600/156 , C12Q2600/158 , G01N2333/96466
摘要: The present invention relates to a method of monitoring and/or modulating disease-associated activatory procceses which are mediated by caspase-10 or caspase-10 isoforms.
摘要翻译: 本发明涉及监测和/或调节由半胱天冬酶-10或半胱天冬酶-10同种型介导的与疾病相关的激活过程的方法。
-
公开(公告)号:US20130195884A1
公开(公告)日:2013-08-01
申请号:US13519955
申请日:2010-12-30
IPC分类号: A61K38/17 , A61K38/48 , A61K38/53 , G01N33/68 , A61K45/06 , A61K39/395 , C12Q1/68 , A61K38/46 , A61K38/50
CPC分类号: A61K38/1709 , A61K38/177 , A61K38/465 , A61K38/4813 , A61K38/50 , A61K38/53 , A61K39/3955 , A61K45/06 , C07K14/4747 , C07K14/70575 , C12Q1/6876 , G01N33/6863
摘要: The present invention relates to an agent for use as a modulator of apoptosis-factor-associated cell death, apoptosis, cell survival, migration and/or proliferation, a method of diagnosing or monitoring apoptosis-factor-associated conditions or disorders as well as a method of identifying a modulator of apoptosis-factor-associated cell death, apoptosis, cell survival, migration and/or proliferation. Preferably, the invention relates to TRAIL-induced cell death and/or TRAIL-induced apoptosis. Preferably the agents are used to stimulate and/or enable TRAIL-induced cell death or to inhibit TRAIL-induced cell death. The preferable use of the diagnostic tools is to diagnose sensitivity or resistance to TRAIL-induced cell death or induction of sensitivity or resistance to TRAIL-induced cell death by an agent.
摘要翻译: 本发明涉及用作凋亡因子相关细胞死亡,凋亡,细胞存活,迁移和/或增殖的调节剂的试剂,诊断或监测凋亡因子相关病症或病症的方法以及 识别凋亡因子相关细胞死亡,凋亡,细胞存活,迁移和/或增殖的调节剂的方法。 优选地,本发明涉及TRAIL诱导的细胞死亡和/或TRAIL诱导的凋亡。 优选地,所述试剂用于刺激和/或使TRAIL诱导的细胞死亡或抑制TRAIL诱导的细胞死亡。 诊断工具的优选使用是诊断TRAIL诱导的细胞死亡的敏感性或抗性或诱导TRAIL诱导的细胞死亡的敏感性或抗性。
-
公开(公告)号:US06642358B1
公开(公告)日:2003-11-04
申请号:US09578392
申请日:2000-05-25
申请人: Charles Rauch , Henning Walczak
发明人: Charles Rauch , Henning Walczak
IPC分类号: C07K1400
CPC分类号: C07K16/2878 , A61K38/00 , C07K14/70578 , C07K14/715 , C07K2317/34
摘要: A protein designated TRAIL receptor binds the protein known as TNF-Related Apoptosis-Inducing Ligand (TRAIL). The TRAIL receptor finds use in purifying TRAIL or inhibiting activities thereof. Isolated DNA sequences encoding TRAIL-R polypeptides are provided, along with expression vectors containing the DNA sequences, and host cells transformed with such recombinant expression vectors. Antibodies that are immunoreactive with TRAIL-R are also provided.
-
公开(公告)号:US6072047A
公开(公告)日:2000-06-06
申请号:US883036
申请日:1997-06-26
申请人: Charles Rauch , Henning Walczak
发明人: Charles Rauch , Henning Walczak
IPC分类号: C12N15/09 , A61K38/00 , A61P43/00 , C07K14/705 , C07K14/715 , C07K16/28 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N15/12 , C12P21/08 , C07H21/04 , C12N15/63
CPC分类号: C07K16/2878 , C07K14/70578 , C07K14/715 , A61K38/00 , C07K2317/34
摘要: A protein designated TRAIL receptor binds the protein known as TNF-Related Apoptosis-Inducing Ligand (TRAIL). The TRAIL receptor finds use in purifying TRAIL or inhibiting activities thereof. Isolated DNA sequences encoding TRAIL-R polypeptides are provided, along with expression vectors containing the DNA sequences, and host cells transformed with such recombinant expression vectors. Antibodies that are immunoreactive with TRAIL-R are also provided.
-
公开(公告)号:US08007813B2
公开(公告)日:2011-08-30
申请号:US10551004
申请日:2004-03-26
申请人: Henning Walczak
发明人: Henning Walczak
CPC分类号: C07K16/2875 , A61K2039/505 , C07K14/70575 , C07K14/70578 , C07K16/2878 , C07K2319/30
摘要: The invention relates to fusion proteins comprising at least a first domain and a second domain selected from a constant Fc immunoglobulin domain.
摘要翻译: 本发明涉及包含至少第一结构域和选自恒定Fc免疫球蛋白结构域的第二结构域的融合蛋白。
-
公开(公告)号:US20070269449A1
公开(公告)日:2007-11-22
申请号:US10551004
申请日:2004-03-26
申请人: Henning Walczak
发明人: Henning Walczak
IPC分类号: A61K39/395 , C07H21/04 , C07K14/715
CPC分类号: C07K16/2875 , A61K2039/505 , C07K14/70575 , C07K14/70578 , C07K16/2878 , C07K2319/30
摘要: The invention relates to fusion proteins comprising at least a first domain and a second domain selected from a constant Fc immunoglobulin domain.
摘要翻译: 本发明涉及包含至少第一结构域和选自恒定Fc免疫球蛋白结构域的第二结构域的融合蛋白。
-
公开(公告)号:US20110305697A1
公开(公告)日:2011-12-15
申请号:US13213345
申请日:2011-08-19
申请人: Henning Walczak
发明人: Henning Walczak
IPC分类号: A61K39/395 , C07H21/00 , C12N15/63 , A61K31/7088 , C12N1/21 , C12N1/19 , C12N5/10 , A61P37/06 , A61P9/00 , A61P9/10 , A61P37/02 , A61P25/00 , A61P29/00 , A61P1/16 , A61P43/00 , A61P13/12 , C07K19/00
CPC分类号: C07K16/2875 , A61K2039/505 , C07K14/70575 , C07K14/70578 , C07K16/2878 , C07K2319/30
摘要: The invention relates to fusion proteins comprising at least a first domain and a second domain selected from a constant Fc immunoglobulin domain; wherein there is at least one amino acid overlap between the first domain and the second domain in the fusion region. In a preferred embodiment of the invention, the first domain is a ligand-binding receptor domain comprising the extra-cellular domain of a membrane-anchored receptor or a ligand-binding fragment thereof.
摘要翻译: 本发明涉及包含至少第一结构域和选自恒定Fc免疫球蛋白结构域的第二结构域的融合蛋白; 其中在融合区域中第一结构域和第二结构域之间存在至少一个氨基酸重叠。 在本发明的优选实施方案中,第一结构域是包含膜锚定受体的细胞外结构域或其配体结合片段的配体结合受体结构域。
-
公开(公告)号:US20100015137A1
公开(公告)日:2010-01-21
申请号:US12343429
申请日:2008-12-23
申请人: Charles Rauch , Henning Walczak
发明人: Charles Rauch , Henning Walczak
IPC分类号: A61K39/395
CPC分类号: C07K14/70578 , A61K38/00 , C07K1/22 , C07K14/715
摘要: A protein designated TRAIL receptor binds the protein known as TNF-Related Apoptosis-Inducing Ligand (TRAIL). The TRAIL receptor finds use in purifying TRAIL or inhibiting activities thereof. Isolated DNA sequences encoding TRAIL-R polypeptides are provided, along with expression vectors containing the DNA sequences, and host cells transformed with such recombinant expression vectors. Antibodies that are immunoreactive with TRAIL-R are also provided.
摘要翻译: 称为TRAIL受体的蛋白质结合称为TNF相关凋亡诱导配体(TRAIL)的蛋白质。 TRAIL受体可用于纯化TRAIL或抑制其活性。 提供了编码TRAIL-R多肽的分离的DNA序列,以及含有DNA序列的表达载体和用这些重组表达载体转化的宿主细胞。 还提供了与TRAIL-R免疫反应的抗体。
-
公开(公告)号:US07528239B1
公开(公告)日:2009-05-05
申请号:US09378045
申请日:1999-08-20
申请人: Charles Rauch , Henning Walczak
发明人: Charles Rauch , Henning Walczak
IPC分类号: C07K16/00 , A61K39/395 , A61K39/00
CPC分类号: C07K14/70578 , A61K38/00 , C07K1/22 , C07K14/715
摘要: A protein designated TRAIL receptor binds the protein known as TNF-Related Apoptosis-Inducing Ligand (TRAIL). The TRAIL receptor finds use in purifying TRAIL or inhibiting activities thereof. Isolated DNA sequences encoding TRAIL-R polypeptides are provided, along with expression vectors containing the DNA sequences, and host cells transformed with such recombinant expression vectors. Antibodies that are immunoreactive with TRAIL-R are also provided.
摘要翻译: 称为TRAIL受体的蛋白质结合称为TNF相关凋亡诱导配体(TRAIL)的蛋白质。 TRAIL受体可用于纯化TRAIL或抑制其活性。 提供了编码TRAIL-R多肽的分离的DNA序列,以及含有DNA序列的表达载体,以及用这些重组表达载体转化的宿主细胞。 还提供了与TRAIL-R免疫反应的抗体。
-
公开(公告)号:US20070207160A1
公开(公告)日:2007-09-06
申请号:US11705956
申请日:2007-02-14
申请人: Peter Krammer , Michael Westendorp , Klaus Schulze-Osthoff , Klaus-Michael Debatin , Rainer Frank , Jens Dhein , Henning Walczak , Eckart Knipping , Kirstin Stricker
发明人: Peter Krammer , Michael Westendorp , Klaus Schulze-Osthoff , Klaus-Michael Debatin , Rainer Frank , Jens Dhein , Henning Walczak , Eckart Knipping , Kirstin Stricker
IPC分类号: A61K39/00
CPC分类号: C07K16/2878 , A61K38/55 , A61K2039/505 , C07K14/70578 , C07K2317/54 , C07K2319/00 , C07K2319/30
摘要: This invention relates to compositions for inhibiting apoptosis, containing one to all components of: (a) an APO-1-inhibiting compound; (b) a compound inhibiting and catching, respectively, the APO-1 ligand; and (c) a compound inhibiting the intracellular APO-1 signalling pathway, the component(s) being not considered foreign in an individual, as well as conventional excipients. Furthermore, this invention relates to compounds suitable for inhibiting apoptosis and having at least one extracellular APO-1 domain and a carrier, the domain(s) and the carrier being not considered foreign in an individual.
摘要翻译: 本发明涉及抑制细胞凋亡的组合物,其含有以下组分之一:(a)APO-1抑制化合物; (b)分别抑制和捕获APO-1配体的化合物; 和(c)抑制细胞内APO-1信号传导途径的化合物,所述组分在个体中不被认为是外源的,以及常规的赋形剂。 此外,本发明涉及适用于抑制凋亡并具有至少一个细胞外APO-1结构域和载体的化合物,所述结构域和载体在个体中不被认为是外源的。
-
-
-
-
-
-
-
-
-